ArticleInternal medicine (Tokyo, Japan)2024

Intraventricular Cerliponase Alfa Treatment in a Patient with Advanced Neuronal Ceroid Lipofuscinosis Type 2.

Saki Nakashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.